Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11672775 Treprostinil prodrugs
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Current Assignee
United Therapeutics Corp.
0
Date Filed
January 4, 2021
0
Date of Patent
June 13, 2023
0
Patent Applicant
United Therapeutics Corp.
0
Patent Application Number
17140705
0
Patent Citations
US Patent 7544713 Compounds and methods for delivery of prostacyclin analogs
0
US Patent 7199157 Use of treprostinil to improve kidney functions
0
US Patent 7384978 Compounds and methods for delivery of prostacyclin analogs
0
US Patent 7417070 Compounds and methods for delivery of prostacyclin analogs
0
US Patent 9029607 Protected aldehydes for use as intermediates in chemical syntheses, and processes for their preparation
0
US Patent 9156786 Process to prepare treprostinil, the active ingredient in remodulin®
0
US Patent 9278901 Compounds and methods for delivery of prostacyclin analogs
0
US Patent 9278902 Crystal form of prostaglandin analogue, and preparation method and use thereof
0
US Patent 9278903 Crystal form of prostaglandin analogue, and preparation method and use thereof
0
US Patent 9346738 Process for the preparation of treprostinil and derivatives thereof
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11672775
0
Patent Primary Examiner
Kara R McMillian
0
CPC Code
A61K 31/192
0
A61K 31/216
0
A61K 31/222
0
A61K 31/265
0
A61K 31/27
0
A61K 31/335
0
A61K 9/0019
0
A61P 9/12
0
Find more entities like US Patent 11672775 Treprostinil prodrugs
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE